Clinical trial
Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV)
NCT00681889 is registered in ClinicalTrials.gov with Reza Dana, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV)
- Lead sponsor
- Reza Dana, MD
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 30, 2008
- Completion date
- September 30, 2010
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.